Elixir MD Launches Australia & New Zealand Subsidiary in Exclusive Partnership with High Tech Medical Pty. Ltd.

ELIXIR MD™, Inc., a global pioneer in aesthetic recovery technology, is proud to announce its official entry into the Australian and New Zealand markets. Through the launch of a wholly owned ANZ subsidiary and an exclusive partnership with High Tech Medical Pty Ltd, ELIXIR MD™ continues its mission to redefine surgical recovery—this time in one of the fastest-growing cosmetic surgery markets worldwide. 

Australia and New Zealand: A Rising Hub for Facial Aesthetic Innovation 

The cosmetic surgery industry in Australia reached an estimated $1.8 billion in 2024, with market growth expected to soar to $3.9 billion by 2033 (IMARC Group, Rentech Digital). Notably, Face & Head surgery—ELIXIR MD™’s specialty—is now the fastest-growing category, expanding at a projected 14.1% CAGR through 2030 (Grand View Research). 

This regional growth is fueled by: 

• Increased demand for blepharoplasty, facelifts, and skin rejuvenation 
• A surge in post-weight-loss aesthetic procedures 
• A shift toward non-invasive, recovery-accelerating technology 
   

ELIXIR MD™: A New Standard in Surgical Recovery 

ELIXIR MD™ delivers FDA-cleared, non-invasive perioperative protocols designed specifically for facial plastic surgery. Our platform uses advanced photobiomodulation to stimulate cellular repair, detoxify the skin preoperatively, and support rapid healing with less pain, swelling, and downtime. 

Key Benefits for Surgeons and Patients: 

• Faster recovery and return to daily activity 
• Reduction in swelling, bruising, and post-op discomfort 
• Seamless integration into facelift, neck lift, and blepharoplasty workflows 
• Backed by over 20,000 treatment hours worldwide 

“The ELIXIR MD™ device and its proprietary treatment protocols represent a new gold standard in post-surgical recovery by significantly reducing patient downtime and improving outcomes.” 

 — Matt Moncrieff, Managing Director, High Tech Medical Pty Ltd. 

High Tech Medical: A Strategic Partner in Aesthetic Medical Technology 

With over 25 years of trusted relationships across the ANZ aesthetic medical community, High Tech Medical Pty Ltd. is a natural partner for this expansion. Known for introducing advanced systems and supporting practitioners with consultative integration, their team will ensure ELIXIR MD™ reaches leading plastic surgeons across Australia and New Zealand. 

“We’re proud to join forces with High Tech Medical—Australia and New Zealand’s leading medical technology ally—to bring the ELIXIR MD™ device to facial surgery patients across one of the world’s fastest-growing cosmetic markets.” 

 — Ewan Mohammed, CEO, ELIXIR MD™ 

What’s Next for Recovery in Australia & New Zealand? 

Plastic surgeons in ANZ can now access a globally proven, non-invasive recovery system designed to: 

• Improve post-operative satisfaction and clinical outcomes 
• Deliver faster healing timelines with fewer complications 
• Differentiate practices through science-backed recovery innovation 

For Patients: 

• Less downtime 
• Reduced inflammation and pain 
• A more relaxing and confident post-surgery experience 

ELIXIR MD™’s Global Vision: Healing Without Borders 

Now operating in 18 global markets, ELIXIR MD™ continues to push the boundaries of perioperative innovation through strategic partnerships, science, and patient-first technology. 

This launch in Australia and New Zealand reflects our unwavering belief that great recovery knows no borders.